Assessment of Giant Cell Arteritis Medical Practices in France

NCT03658889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2022-07-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe medical practices in patients with GCA in terms of patient journey, diagnostic methods and specific GCA treatments since diagnosis.

Conditions

  • Giant Cell Arteritis

Sponsors & Collaborators

  • ITEC Services

    collaborator OTHER
  • Chugai Pharma France

    lead INDUSTRY

Principal Investigators

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-02
Primary Completion
2018-11-09
Completion
2018-11-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658889 on ClinicalTrials.gov